Anthony Pare
Nessuna posizione attualmente
Patrimonio netto: - $ in data 30/04/2024
Profilo
Anthony Pare served as the Chief Executive Officer at Bioporto A from 2021 to 2024.
Prior to that, he was the Chief Commercial Officer at Hemanext, Inc. and T2 Biosystems, Inc. He also held the position of VP & General Manager-Global Services at Haemonetics Corp.
In terms of education, he received a graduate degree from George Washington University and an undergraduate degree from Maine Maritime Academy.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
BIOPORTO A/S
-.--% | 31/12/2022 | 0 ( -.--% ) | - $ | 30/04/2024 |
Precedenti posizioni note di Anthony Pare
| Società | Posizione | Fine |
|---|---|---|
| BIOPORTO A/S | Chief Executive Officer | 09/01/2024 |
| T2 BIOSYSTEMS, INC. | Corporate Officer/Principal | 08/11/2021 |
Hemanext, Inc.
 Hemanext, Inc. Medical SpecialtiesHealth Technology Hemanext, Inc. develops blood storage systems. Its technology includes anaerobic storage, background on stored blood, science of storage lesion, and clinical implications. The company was founded by Martin A. Cannon and is headquartered in Lexington, MA. | Corporate Officer/Principal | - |
| HAEMONETICS CORPORATION | Corporate Officer/Principal | - |
Formazione di Anthony Pare
| George Washington University | Graduate Degree |
| Maine Maritime Academy | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| HAEMONETICS CORPORATION | Health Technology |
| BIOPORTO A/S | Health Technology |
| T2 BIOSYSTEMS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Hemanext, Inc.
Hemanext, Inc. Medical SpecialtiesHealth Technology Hemanext, Inc. develops blood storage systems. Its technology includes anaerobic storage, background on stored blood, science of storage lesion, and clinical implications. The company was founded by Martin A. Cannon and is headquartered in Lexington, MA. | Health Technology |
- Borsa valori
- Insiders
- Anthony Pare
